Core Viewpoint - Southbound funds have significantly reduced their holdings in Zhiyun Health (09955.HK), indicating a potential shift in investor sentiment towards the company [1]. Group 1: Shareholding Changes - On October 21, 2025, southbound funds reduced their holdings by 399,000 shares, a decrease of 0.77% [2]. - Over the past five trading days, there have been reductions in holdings for five days, totaling a net decrease of 588,100 shares [1]. - In the last twenty trading days, southbound funds have reduced their holdings for all twenty days, with a cumulative net reduction of 1,625,000 shares [1]. Group 2: Current Holdings - As of the latest data, southbound funds hold 51,608,400 shares of Zhiyun Health, which represents 7.98% of the company's total issued ordinary shares [1]. Group 3: Company Overview - Zhiyun Health Technology Group is a Chinese holding company primarily engaged in providing medical services and products [2]. - The company's offerings include hospital medical supplies, SaaS products for hospitals, digital marketing services for pharmaceutical companies, and online consultation and prescription services for patients [2]. - The product portfolio consists of three main categories: in-hospital solutions, pharmacy solutions, and personal chronic disease management solutions [2].

证券之星消息，10月15日南向资金减持3.01万股智云健康（09955.HK）。近5个交易日中，获南向资金 减持的有5天，累计净减持60.41万股。近20个交易日中，获南向资金减持的有20天，累计净减持495.9万 股。截至目前，南向资金持有智云健康（09955.HK）5216.37万股，占公司已发行普通股的8.07%。 智云健康科技集团是一家主要从事提供医疗服务和产品的中国控股公司。该公司为医院和药店提供医疗 用品和软件即服务（SaaS）产品，为制药公司提供数字营销服务，为患者提供在线问诊和处方开具。该 公司的产品组合主要包括三大产品或服务类别。院内解决方案主要包括医院医疗用品供应、医院SaaS和 数字营销服务。药店解决方案主要包括药店用品供应和药店SaaS。个人慢病管理解决方案及其他主要包 括慢病产品、会员服务，以及保险经纪服务、广告代理服务及其他。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 | 交易日 | 持股总数 (股) | 持股变动(股) | 变动幅度 | | --- | --- | --- | --- | | 20 ...